Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
Trial details
- Registry ID
- NCT03588026
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576NCT03588026 | AKARI Therapeutics | Phase 3 | Completed | 2020-09-03Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |